ORCHID PHARMA LIMITED Financial Ratios
ORCHPHARMA · Healthcare · Current price ₹1,041.35
P/E ratio
257.1x
P/B ratio
3.9x
ROE
2.1%
ROCE
3.0%
Debt / Equity
0.28
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 257.1x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 3.9x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 2.1% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 3.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.28 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with ORCHID PHARMA LIMITED's latest numbers.
ORCHID PHARMA LIMITED profitability
ORCHID PHARMA LIMITED generates a return on equity of 2.1% and a return on capital employed of 3.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.28 and a P/E of 257.1x, ORCHID PHARMA LIMITED is conservatively financed. Our overall business-quality score for the company is 2.4 / 10.
Understand the ratios
More on ORCHID PHARMA LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.